Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimal Residual Disease: A Trial Using Liquid Biopsies in Solid Malignancies.

NCT04853420 is registered in ClinicalTrials.gov with University of Leicester as lead sponsor.

NCT NCT04853420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04853420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimal Residual Disease: A Trial Using Liquid Biopsies in Solid Malignancies.
Lead sponsor
University of Leicester
Phase
Observational
Overall status
Unknown status
Start date
February 16, 2021
Completion date
April 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer